Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Race Oncology Ltd. ( (AU:RAC) ) has shared an announcement.
Race Oncology Ltd has released its Corporate Governance Statement, emphasizing its commitment to high standards of accountability and transparency. The company has adopted the ASX Corporate Governance Council’s principles, with adjustments to fit its specific circumstances, aiming to ensure effective management and oversight. This announcement underscores Race Oncology’s dedication to robust governance practices, which are fundamental to its growth and beneficial for its shareholders.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of cancer therapies. The company is committed to maintaining high standards of accountability and transparency in its operations.
Average Trading Volume: 93,282
Technical Sentiment Signal: Sell
Current Market Cap: A$205M
See more data about RAC stock on TipRanks’ Stock Analysis page.